LSH contributes to the malignant progression of prostate cancer, melanoma, nasopharyngeal carcinoma, glioma, and non-small cell lung cancer [9, 10, 32, 35–40], Interestingly, LSH might participate in the regulation of cancer cell metabolism [38, 41, 42]. Here, HELLS is linked to prostate cancer.